Bristol-Myers Squibb

NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thu, 06/19/14 - 10:36 am
NICE
Pradaxa
Xarelto
bloodthinners
Eliquis
Bayer
JNJ
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
Expecting hostile suitors, Shire brings in reinforcements
Fierce Pharma
Wed, 06/18/14 - 05:31 am
Shire
M&A
Bristol-Myers Squibb
Amgen
AbbVie
Gilead Sciences
Biogen Idec
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
biotech
generics
Amgen
Roche
Biogen Idec
Eli Lilly
Bristol-Myers Squibb
Sanofi
Novartis
Sandoz
Omnitrope
Genotropin
Bristol-Myers hepatitis B drug patent ruled invalid by appeals court
Yahoo/Fly on the Wall
Thu, 06/12/14 - 11:12 am
hepatitis B
Bristol-Myers Squibb
Teva Pharmaceuticals
patents
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Teva
AbbVie
Boehringer Ingelheim
GSK
Sanofi
Amgen
Eli Lilly
JNJ
AstraZeneca
Roche
Novartis
Merck
Pfizer
Takeda
Bristol-Myers Squibb
3 Pharma Giants Battling for Immuno-Oncology Dominance
Motley Fool
Sat, 06/7/14 - 09:23 am
Bristol-Myers Squibb
Merck
AstraZeneca
Is Bristol-Myers Squibb's Dividend Safe?
Motley Fool
Fri, 06/6/14 - 11:55 am
dividends
Bristol-Myers Squibb
Bristol Shares Sag On Cancer Drug Worries
Forbes
Thu, 06/5/14 - 10:53 pm
Bristol-Myers Squibb
Yervoy
nivolumab
cancer
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thu, 06/5/14 - 12:04 pm
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thu, 06/5/14 - 11:17 am
ASCO
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
MK-3475
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thu, 06/5/14 - 09:14 am
ASCO
Pfizer
Aromasin
tamoxifen
DARA Biosciences
breast cancer
Herceptin
Tykerb
GSK
Eli Lilly
Bristol-Myers Squibb
Erbitux
Bristol-Myers, Syngene International extend research collaboration
Yahoo/Fly on the Wall
Tue, 06/3/14 - 10:25 am
Bristol-Myers Squibb
Syngene International
R&D
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
ASCO
GSK
Puma Biotechnology
Merck
Roche
Bristol-Myers Squibb
Kite
Novartis
Juno Therapeutics
Eli Lilly
Clovis Oncology
AstraZeneca
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
cancer immunotherapy
Merck
MK-3475
Roche
Yervoy
Bristol-Myers Squibb
Merck KGaA
AstraZeneca
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
The Fly on the Wall
Tue, 05/27/14 - 09:14 am
Bristol-Myers Squibb
Incyte
nivolumab
melanoma
non-small cell lung cancer
colorectal cancer
ovarian cancer
INCB24360
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Yahoo/Zacks.com
Thu, 05/22/14 - 08:36 am
Incyte
Celldex
Bristol-Myers Squibb
AstraZeneca
Halozyme
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
The Fly on the Wall
Mon, 05/19/14 - 09:17 am
Bristol-Myers Squibb
AbbVie
elotuzumab
Multiple Myeloma
Could Bristol-Myers End Up Acquiring Celldex?
Motley Fool
Thu, 05/15/14 - 05:55 pm
Celldex
M&A
Bristol-Myers Squibb

Pages